Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience

Jessica Slostad, Patrick Hoversten, Candace L. Haddox, Kamila Cisak, Jonas Paludo, Ayalew Tefferi

Research output: Contribution to journal › Article

20 Scopus citations

Original language	English (US)
Journal	American Journal of Hematology
DOIs	https://doi.org/10.1002/ajh.24971
State	Accepted/In press - Jan 1 2017

Cite this

@article{9fc6bb9e4a1740a2ae5b62a7d8cd643c,

title = "Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience",

author = "Jessica Slostad and Patrick Hoversten and Haddox, {Candace L.} and Kamila Cisak and Jonas Paludo and Ayalew Tefferi",

year = "2017",

month = jan,

day = "1",

doi = "10.1002/ajh.24971",

language = "English (US)",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis

T2 - A single patient experience

AU - Slostad, Jessica

AU - Hoversten, Patrick

AU - Haddox, Candace L.

AU - Cisak, Kamila

AU - Paludo, Jonas

AU - Tefferi, Ayalew

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85037350538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037350538&partnerID=8YFLogxK

U2 - 10.1002/ajh.24971

DO - 10.1002/ajh.24971

M3 - Article

C2 - 29134683

AN - SCOPUS:85037350538

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

ER -